Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reactive oxygen species (ROS) generation in Plasmodium-infected erythrocytes is a process arising from both host and parasite metabolism during malaria infection, primarily involving hydrogen peroxide, superoxide, and hydroxyl radicals. ROS are produced in the food vacuole of the parasite during hemoglobin digestion and also by host enzymes such as xanthine oxidase and phagocyte NADPH oxidase. While ROS contribute to oxidative damage and inflammation in malaria pathogenesis—including the development of severe complications—they also have a host-protective role by inhibiting parasite growth. In malaria patients, especially during severe disease, elevated ROS (notably from upregulated xanthine oxidase) drive inflammation and tissue damage, as well as providing signals for inflammasome activation[1][2][4][5][6][7].
Scavenging or reduction of ROS to mitigate cellular damage[5][6][7] Inhibition of xanthine oxidase to reduce ROS-mediated inflammation[5][6]
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen species generation in Plasmodium-infected erythrocytes.